Form 8-K - Current report:
SEC Accession No. 0001104659-24-108583
Filing Date
2024-10-15
Accepted
2024-10-15 16:06:36
Documents
15
Period of Report
2024-10-15
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2426167d1_8k.htm   iXBRL 8-K 30313
2 EXHIBIT 3.1 tm2426167d1_ex3-1.htm EX-3.1 43634
3 EXHIBIT 3.2 tm2426167d1_ex3-2.htm EX-3.2 76698
  Complete submission text file 0001104659-24-108583.txt   361833

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA camp-20241015.xsd EX-101.SCH 3012
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE camp-20241015_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE camp-20241015_pre.xml EX-101.PRE 22357
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2426167d1_8k_htm.xml XML 3943
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Filer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42365 | Film No.: 241371901
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)